Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
ESMO Open
|
March 22, 2023
Systemic treatment of metastatic hormone-sensitive prostate cancer-upfront triplet versus doublet combination therapy
C Oing, R G Bristow
International Journal of Radiation Oncology, Biology, Physics
|
February 1, 1990
Comparison between in vitro radiosensitivity and in vivo radioresponse in murine tumor cell lines. II: In vivo radioresponse following fractionated treatment and in vitro/in vivo correlations
R G Bristow, R P Hill
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 10, 2020
Intermediate Risk Prostate Cancer: Disease Heterogeneity Linked to Measurable Biological Features
R J Rebello, R G Bristow
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 18, 2005
Radiotherapy and Marfan syndrome: a report of two cases
M Finlay, N Laperriere, R G Bristow
Cancer Treatment Reviews
|
January 19, 2010
Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: a good thing?
A Tabassum, R G Bristow, V Venkateswaran
International Journal of Radiation Oncology, Biology, Physics
|
July 15, 1996
p53 protein expression or protein function?
R G Bristow, S Benchimol, R Hill
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 1, 1996
The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy
R G Bristow, S Benchimol, R P Hill
The British Journal of Radiology
|
March 5, 2014
An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy
R G Bristow, A Berlin, A Dal Pra
The British Journal of Radiology
|
November 4, 2014
Pre-radiotherapy identification of individual genomic profile to avoid, by resort to customized radiosensitizers, the risk of radioresistance development in patients with localized prostate cancer: author reply
A Berlin, A Dal Pra, R G Bristow
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1990
Comparison between in vitro radiosensitivity and in vivo radioresponse of murine tumor cell lines. I: Parameters of in vitro radiosensitivity and endogenous cellular glutathione levels
R G Bristow, P A Hardy, R P Hill
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
ESMO Open
|
March 22, 2023
Systemic treatment of metastatic hormone-sensitive prostate cancer-upfront triplet versus doublet combination therapy
C Oing, R G Bristow
International Journal of Radiation Oncology, Biology, Physics
|
February 1, 1990
Comparison between in vitro radiosensitivity and in vivo radioresponse in murine tumor cell lines. II: In vivo radioresponse following fractionated treatment and in vitro/in vivo correlations
R G Bristow, R P Hill
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
March 10, 2020
Intermediate Risk Prostate Cancer: Disease Heterogeneity Linked to Measurable Biological Features
R J Rebello, R G Bristow
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
February 18, 2005
Radiotherapy and Marfan syndrome: a report of two cases
M Finlay, N Laperriere, R G Bristow
Cancer Treatment Reviews
|
January 19, 2010
Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: a good thing?
A Tabassum, R G Bristow, V Venkateswaran
International Journal of Radiation Oncology, Biology, Physics
|
July 15, 1996
p53 protein expression or protein function?
R G Bristow, S Benchimol, R Hill
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
September 1, 1996
The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy
R G Bristow, S Benchimol, R P Hill
The British Journal of Radiology
|
March 5, 2014
An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy
R G Bristow, A Berlin, A Dal Pra
The British Journal of Radiology
|
November 4, 2014
Pre-radiotherapy identification of individual genomic profile to avoid, by resort to customized radiosensitizers, the risk of radioresistance development in patients with localized prostate cancer: author reply
A Berlin, A Dal Pra, R G Bristow
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1990
Comparison between in vitro radiosensitivity and in vivo radioresponse of murine tumor cell lines. I: Parameters of in vitro radiosensitivity and endogenous cellular glutathione levels
R G Bristow, P A Hardy, R P Hill
Page
of 4